{"news_desk": "Business", "print_page": "2", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By LANDON THOMAS Jr", "person": [{"firstname": "Landon", "lastname": "THOMAS", "rank": 1, "role": "reported", "qualifier": "Jr", "organization": ""}]}, "abstract": "Pershing Square Capital Management owner William A Ackman admits he underestimated complexities surrounding Valeant Pharmaceuticals; Ackman's hedge fund was negatively impacted when troubled drug firm's stock fell sharply last quarter. ", "type_of_material": "News", "word_count": "510", "lead_paragraph": "William A. Ackman said the drug company Valeant was undervalued and had potential but its decline had affected his firm, Pershing Square.", "pub_date": "2016-04-07T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Ackman Defends Pershing Square\u2019s Large Stake in Valeant", "print_headline": "Business Briefing; Ackman Defends Holding in Beleaguered Valeant"}, "snippet": "William A. Ackman said the drug company Valeant was undervalued and had potential but its decline had affected his firm, Pershing Square.", "multimedia": [{"height": 126, "url": "images/2016/04/07/business/07db-ackman/07db-ackman-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/04/07/business/07db-ackman/07db-ackman-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 392, "url": "images/2016/04/07/business/07db-ackman/07db-ackman-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "392", "xlarge": "images/2016/04/07/business/07db-ackman/07db-ackman-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/04/07/business/07db-ackman/07db-ackman-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/04/07/business/07db-ackman/07db-ackman-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/04/07/business/dealbook/ackman-defends-pershing-squares-large-stake-in-valeant.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Pershing Square Capital Management", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Ackman, William A", "name": "persons"}, {"rank": "4", "is_major": "N", "value": "Hedge Funds", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Pearson, John Michael (1959- )", "name": "persons"}], "blog": [], "_id": "57054e9638f0d86865ca518f", "source": "The New York Times"}